GE gets FDA nod for Visipaque CCTA indication

AuntMinnie.com staff writers
May 1, 2017
2017 02 23 12 24 16 608 Ge Rsna 2016 Square 20170223192440

GE Healthcare has received U.S. Food and Drug Administration (FDA) clearance for a new indication for its Visipaque contrast agent.

The iso-osmolar agent is now approved for use in coronary CT angiography (CCTA) to assist in the diagnostic evaluation of adults and pediatric patients 12 years or older with suspected coronary artery disease.

Radiologists and cardiologists have traditionally used invasive coronary angiography procedures to diagnose potential coronary artery disease in patients, but the new Visipaque indication allows for imaging the coronary arteries of these patients in an outpatient CCTA procedure, according to the vendor.

Latest in CT
3 D Lungs Covid Virus Cells
CT reveals influence of diabetes on COVID-19 severity
April 25, 2024
Lung Illustration Blue
Clinical practice LCS program finds more disease than NLST
April 24, 2024
You think ahead. We innovate ahead.
Sponsored
You think ahead. We innovate ahead.
April 25, 2024
Doctor Female Young Desk 400
Radiologist consultation improves patients' LCS attitudes
April 18, 2024
Related Stories
2017 06 12 09 25 59 649 Flannery John 400
Industry News
Flannery named as GE chief as Immelt to retire
2017 02 23 12 24 16 608 Ge Rsna 2016 Square 20170223192440
Artificial Intelligence
GE, Partners HealthCare team up for deep-learning venture
2017 04 28 11 12 37 891 Signa Premier
MRI
GE submits 510(k) for wide-bore MRI scanner
Lung cancer screening that meets your patients’ needs
Sponsor Content
Lung cancer screening that meets your patients’ needs
More in CT
CT reveals influence of diabetes on COVID-19 severity
By Kate Madden Yee
CT imaging reveals the influence of blood glucose levels on the severity of COVID-19, researchers have reported.
April 25, 2024
3 D Lungs Covid Virus Cells
Clinical practice LCS program finds more disease than NLST
By Kate Madden Yee
A clinical practice lung cancer screening (LCS) program at Duke University Medical Center found more disease than did the National Lung Screening Trial (NLST).
April 24, 2024
Lung Illustration Blue
Novel risk prediction model improves LCS uptake
By Kate Madden Yee
A novel risk prediction model used in the Ontario Lung Cancer Screening Pilot increased the uptake of lung cancer screening among eligible Canadians, researchers have found.
April 23, 2024
Lung Cancer
Radiologist consultation improves patients' LCS attitudes
By Kate Madden Yee
Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.
April 18, 2024
Doctor Female Young Desk 400
Tailored lung cancer screening model helps determine nodule follow-up
By Kate Madden Yee
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.
April 17, 2024
Lung Cancer
CT-based deep learning identifies patients at further lung cancer risk
By Kate Madden Yee
A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.
April 16, 2024
Ai
CT-FFR reduces invasive procedures for coronary artery blockages
By Kate Madden Yee
CT fractional flow reserve (CT-FFR) imaging identifies patients with coronary artery blockage or narrowing who could benefit from revascularization -- and helps reduce the unnecessary use of invasive procedures, researchers have found.
April 11, 2024
Heart Pulmonary Trunk
Experts say consider BMI when imaging patients with chest pain
By Will Morton
A patient’s body mass index (BMI) has a significant effect on how much radiation exposure they receive from chest imaging in cases of suspected cardiac ischemia.
April 11, 2024
Heart Attack
AI model predicts invasiveness of lung cancer on CT scans
By Will Morton
Radiologists in Beijing, China, have developed a joint deep-learning and radiomics AI model that can flag how invasive tumors may be in patients with lung cancer.
April 9, 2024
Lung Ai
Is CTA overused in the emergency department?
By Amerigo Allegretto
CT angiography (CTA) may be overused in the emergency department, new research suggests.
April 1, 2024
Patient Elderly Confused Headache 400
Deep learning helps distinguish benign vertebral fractures on CT
By Kate Madden Yee
A deep-learning algorithm used with CT imaging can differentiate between benign and malignant vertebral fractures, researchers have found.
March 27, 2024
Overview of the automated deep learning-based pipeline. Multidetector CT images show the (A) original data, (B, C) vertebral segmentation, and (D-F) vertebral labeling during preprocessing. Images and caption courtesy of the RSNA.
The rise of theranostics: Part 1 -- Gaining momentum
By Liz Carey
FDA-approved radiopharmaceuticals have energized the field of theranostics. In part 1 of a series, experienced theranostics leaders offer implications of the latest clinical trials, how a theranostics clinic works, and advice for introducing theranostics.
March 26, 2024
Team members from the theranostics clinic under University of Texas Health Science Center at San Antonio's Department of Radiology show one aspect of a Pluvicto infusion treatment. The L block lead shield over the syringe helps protect certified nuclear medicine technologist James Johnson (left), and nuclear radiologist Penny Vroman, MD (right), from radiation emitted by the drug. (Photo courtesy of UT Health San Antonio Department of Radiology)
Page 1 of 654
Next Page